By Francis Gano Benedict, Elliott Proctor Joslin PART I. INTRODUCTION.   Perhaps no chronic disease makes such rapid inroads on health, strength, and weight as does diahetes. The large amounts of sugar in the urine, the polydipsia, polyphagia, and polyuria are observations so common in many cases that it is …

We all know that insulin dosing mistakes are the number one medical error, but what happens when our patients don’t take enough insulin? They often develop DKA or HHS. How often do these occur, why do they occur, what is the difference and how do you diagnose and treat them? …

Lana Kravarusic Doctor of Pharmacy Candidate, University of Florida 

Light and Moderate Physical Activity Reduce the Risk of Early Death by 19%: A new study by researchers has found that even light or moderate intensity physical activity, such as walking or cycling, can substantially reduce the risk of early death. The study combined the results from the largest studies …

Dietary Habits of African-Americans Are Similar, Diabetes or Not: African Americans are 1.8 times more likely to develop Type 2 diabetes and 1.4 times more likely to be obese than are non-Hispanic whites. Researchers looking for differences in the eating habits of African Americans based on whether or not they …

D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development: D-Tagatose, first in class, to treat diabetes could be the next new drug approved for diabetes and for the treatment of hypertriglyceridemia levels, pending results of the NEET trial. The effect on triglycerides is a secondary endpoint of the …

Cycloset New First in Class Type 2 Diabetes Drug Cycloset Available November 2010. VeroScience announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize Cycloset®, which has been approved by the FDA as an adjunct to diet and exercise to improve …

Roche Suspends Dosing in Drug Trials for its GLP-1 Compound, Taspoglutide. See this week’s Item #6.

Amyloid could “directly poison” pancreas cells. Shedding light on how a malfunctioning protein helps trigger Type 2 diabetes could one day offer the chance to halt the damage, say scientists…. 

VeroScience announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize Cycloset®, which has been approved by the FDA as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes both as mono-therapy and in …